NAIINasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends June 30
NATURAL ALTERNATIVES INTERNATIONAL INC
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 28, 2026
$1.15+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $6.98M
- P/E (TTM)
- –
- Dividend yield
- –
NATURAL ALTERNATIVES INTERNATIONAL INC revenue by segment
By business segment
| Revenue | Q4 26 | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Private Label Contract Manufacturing [Member] | $31.94M | $33.81M | $32.80M | $36.07M | $31.76M | $27.08M | $32.32M | $30.63M | $27.64M | $22.48M | $23.05M | $32.19M | 92.5% | +0.6% |
| Patent and Trademark Licensing [Member] | $2.57M | $1.67M | $1.99M | $1.67M | $2.11M | $1.69M | $1.76M | $2.52M | $1.85M | $2.66M | $2.15M | $1.78M | 7.5% | +22.0% |
| Operating income | Q4 26 | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patent and Trademark Licensing [Member] | $867.00K | $544.00K | $569.00K | $712.00K | $961.00K | $734.00K | $714.00K | $997.00K | $727.00K | $1.20M | $947.00K | $443.00K | -9.8% |
| Private Label Contract Manufacturing [Member] | -$11.80M | -$2.28M | -$176.00K | $1.80M | $629.00K | -$556.00K | -$1.16M | -$645.00K | -$1.10M | -$1.01M | -$2.37M | $1.01M | -1976.0% |
By product or service
By region
| Revenue | Q4 26 | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | – | – | – | – | $19.49M | $18.25M | $20.75M | $20.63M | $16.52M | $15.46M | $16.59M | $24.95M | – | – |
| Non-US [Member] | – | – | – | – | $14.37M | $10.52M | $13.33M | $12.52M | $12.97M | $9.68M | $8.62M | $9.02M | – | – |
From the segment and revenue-disaggregation notes of Natural Alternatives International's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.